Calliditas Therapeutics
Teona Pipiya Johnson is a marketing professional with significant experience in the pharmaceutical industry. Teona is currently the Vice President Marketing at Calliditas Therapeutics and previously held various marketing leadership roles at Pfizer. Teona also has a background in marketing analytics and business strategy from their time at Roche Pharmaceuticals. Teona holds an MBA from NYU Stern School of Business and a degree in Biology/Genetics from Cornell University.
This person is not in any offices
Calliditas Therapeutics
2 followers
Calliditas Therapeutics AB is a specialty pharmaceutical company based in Stockholm, Sweden. It is focused on developing high quality pharmaceutical products for patients with a significant unmet medical need in niche indications, in which Calliditas can partially or completely participate in the commercialization efforts. Calliditas is focused onthe development and commercialization of the product candidate Nefecon, a unique two step formulation optimized to combine a time lag effect with a concentrated release of the active substance budesonide, within a designated target area. This patented, locally acting formulation is intended for treatment of patients with the inflammatory renal disease IgA nephropathy (IgAN). Calliditas is running a global Phase 3 study within IgAN and aims to commercialize Nefecon in the United States.